Thursday, 18 July 2019

iGene Lab gets CAP accreditation for NIPT

22 January 2019 | News

CAP is the world’s largest association composed exclusively of board-certified pathologists and is the global leader in laboratory quality assurance.

iGene Laboratory, a leading Singapore molecular diagnostics company for women's and reproductive health is pleased to announce that it has been awarded the College of American Pathologist (CAP) accreditation for the Non-Invasive Prenatal Test (NIPT). CAP is the world’s largest association composed exclusively of board-certified pathologists and is the global leader in laboratory quality assurance. This recognition adds to the certification previously received from Singapore’s Ministry of Health.

“The CAP accreditation represents the highest benchmark for lab testing in the industry and is based on an entire spectrum of laboratory test disciplines with the most scientifically rigorous customised checklist requirements. iGene is proud to be among a small group of Next Generation Sequencing (NGS)-specialised diagnostic laboratories to receive this accreditation, reaffirming our commitment to achieve the highest standards of excellence to positively impact patient care in Singapore and the region,” said Dr Chang Chia Pin, Vice President, iGene Laboratory.

iGene Laboratory set up a state-of-the art NGS Laboratory in Singapore in 2015, and currently provides testing services to clinics and hospitals in Singapore and the region, including Malaysia, Indonesia, Cambodia and Myanmar. iGene Laboratory is a wholly owned subsidiary of INEX Innovations Exchange and is currently collaborating with world class institutions such as the National University of Singapore and A*Star to develop new technologies in women’s and reproductive health.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls